Possible efficacy of temozolomide in a patient with gliomatosis cerebri

Neurology

Volumn 57, Issue 10, 2001, Pages 1932-1933

  Benjelloun, Ali ^a   Delavelle, Jacqueline ^a   Lazeyras, François ^a   Dietrich, Pierre Yves ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; ANTICONVULSIVE AGENT; TEMOZOLOMIDE;

ADULT; AMNESIA; ARTICLE; BRAIN BIOPSY; BRAIN TUMOR; CANCER SURVIVAL; CASE REPORT; CLINICAL FEATURE; DIAGNOSTIC IMAGING; DRUG EFFECT; DRUG EFFICACY; DRUG INDICATION; DRUG RESPONSE; FOLLOW UP; GLIA CELL; GLIOSIS; HUMAN; IMAGE ANALYSIS; LETHARGY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SEIZURE; SYMPTOM; TREATMENT FAILURE;

EID: 0035960671     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.57.10.1932     Document Type: Article

References (5)

1. Gliomatosis cerebri: Clinical features, treatment, and prognosis
2. Gliomatosis cerebri: Results with radiation therapy
3. Temozolomide and treatment of malignant glioma
4. Metabolic imaging in the diagnosis of brain tumors
5. Volume MRI and MRSI techniques for the quantitation of treatment response in brain tumors: Presentation of a detailed case study